2008•Journal of Clinical HematologyRequires access

Analysis of test results about related pathogenic markers before transfusion in 1242 cases of blood recipients

Yuan Xian-hou

Open publisher page 0 citations

Abstract

Objective:To detect related pathogenic markers before transfusion in order to find out the situation of blood recipients before transfusion and prevent medical disputes caused by clinical blood transfusion.Method:The blood markers of hepatitis B virus , HIV and HCV antibodies were detected by ELISA. The syphilis in 1 242 blood recipients were detected by toluidine red unheated serum test (TRUST). Result:HBsAg's positive rate was 10.15%, HBcAb(IgG)'s positive rate was 10.15%, HBeAg's positive rate was 2.90%, HBeAb's positive rate was 6.28%, HCV antibody' s positive rate was 0.97%, HIV antibody's positive rate was 0%, and syphilis' positive rate was 0.32%. Conclusion:Routes of infection about AIDS, virus hepatitis and syphilis are varied. In order to judge whether caused by transfusion, we should detect related pathogenic markers before transfusion to discover the positive patients promptly. Otherwise it is hard to define infectious origin, and is extremely easy to cause the medical dispute.

About this research paper

What this paper is about

Objective:To detect related pathogenic markers before transfusion in order to find out the situation of blood recipients before transfusion and prevent medical disputes caused by clinical blood transfusion.Method:The blood markers of hepatitis B virus , HIV and HCV antibodies were detected by ELISA. The syphilis in 1 242 blood recipients were detected by toluidine red unheated serum test (TRUST). Result:HBsAg's positive rate was 10.15%, HBcAb(IgG)'s positive rate was 10.15%, HBeAg's positive rate was 2.90%, HBeAb's positive rate was 6.28%, HCV antibody' s positive rate was 0.97%, HIV antibody's positive rate was 0%, and syphilis' positive rate was 0.32%. Conclusion:Routes of infection about AIDS, virus hepatitis and syphilis are varied. In order to judge whether caused by transfusion, we should detect related pathogenic markers before transfusion to discover the positive patients promptly. Otherwise it is hard to define infectious origin, and is extremely easy to cause the medical dispute.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To detect related pathogenic markers before transfusion in order to find out the situation of blood recipients before transfusion and prevent medical disputes caused by clinical blood transfusion.Method:The blood markers of hepatitis B virus , HIV and HCV antibodies were detected by ELISA. The syphilis in 1 242 blood recipients were detected by toluidine red unheated serum test (TRUST). Result:HBsAg's positive rate was 10.15%, HBcAb(IgG)'s positive rate was 10.15%, HBeAg's positive rate was 2.90%, HBeAb's positive rate was 6.28%, HCV antibody' s positive rate was 0.97%, HIV antibody's positive rate was 0%, and syphilis' positive rate was 0.32%. Conclusion:Routes of infection about AIDS, virus hepatitis and syphilis are varied. In order to judge whether caused by transfusion, we should detect related pathogenic markers before transfusion to discover the positive patients promptly. Otherwise it is hard to define infectious origin, and is extremely easy to cause the medical dispute.

Key concepts: Syphilis, HBsAg, Medicine, Blood transfusion, Antibody, HBeAg, Immunology, Hepatitis B virus

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of test results about related pathogenic markers before transfusion in 1242 cases of blood recipients — Research Paper | ScholarLens